Scientific Pillars

Exploiting pathway dependencies to potentially induce cancer death

Targeting DNA damage response (DDR) dependencies, exploiting high levels of tumor replication stress and enhancing tumor sensitivity to DNA-damaging chemotherapies and radiation therapy to identify novel molecules with the potential to induce cancer cell death

Building a pipeline of innovative cell Chimeric Antigen Receptor T cell (CAR-T) and T Cell Receptor (TCR) therapies designed to empower and equip the immune system’s T-cells to more effectively fight cancer

Redirecting the immune system to eliminate cancer

T-cell engagers are a type of bispecific antibody engineered to activate and redirect the immune system’s T cells to recognize and kill cancer cells

A novel approach to deliver targeted radiation directly to cancer cells.

Arming tumor-targeted molecules with payloads that emit ionizing radiation, inducing DNA double-strand breaks to the DNA helix, leading to cell death.

Novel approaches to target cancer’s epigenome

Designing next-generation small-molecule inhibitors that reprogram cancer cells, by targeting epigenetic mechanism such as DNA, RNA and/or histone modifications, with potential to combine with other therapies to deepen response and overcome resistance mechanisms